Skip to main content
KBS_Icon_questionmark link-ico

R&D resources

COVID-19 update 

As the current COVID-19 situation develops, Investigator sites may see the closure of clinics, restricted travel for staff and participants and redeployment of research staff which may adversely impact protocol compliance for participants already enrolled into clinical trials. Protecting participants’ safety and maintaining duty of care to trial participants during this uncertain time is of paramount importance.

Regular contact with participants and vigorous record-keeping will help protect participants’ safety and well-being and help ensure data integrity.

SLaM investigators are asked to check the SLaM intranet and their SLaM email daily and cascade any new information to relevant staff. 

Additional KHP guidance for researchers

Useful links for researchers